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Objective: With an increasing prevalence of older and obese citizens, the problems of knee osteoarthritis
(KOA) will escalate. Weight loss is recommended for obese KOA patients and in a majority of cases this
leads to symptomatic relief. We hypothesized that pre-treatment structural status of the knee joint,
assessed by radiographs, 1.5 T magnetic resonance imaging (MRI) and knee-joint alignment, may
inﬂuence the symptomatic changes following a signiﬁcant weight reduction.
Design: Patients were recruited from a Department of Rheumatology. Eligibility criteria were age above
50 years, body mass index 30 kg/m2, primary KOA diagnosed according to the American College of
Rheumatology (ACR) criteria and having veriﬁed structural damage. Patients underwent a 16 weeks
dietary programme with formula products and counselling. MRI and radiographs of the most symp-
tomatic knee were obtained at baseline and assessed for structural damage using the Boston-Leeds
Osteoarthritis of the Knee Score, minimum joint space width and KellgreneLawrence score. Imaging
variables, muscle strength and degree of alignment, were examined as predictors of changes in Knee
Osteoarthritis Outcome Score (KOOS) and Outcome Measures in Rheumatoid Arthritis Clinical Trials
(OMERACT) - Osteoarthritis Research Society International (OARSI) Responder Criterion.
Results: Structural damage at baseline assessed by imaging, muscle strength or knee-joint alignment
showed no statistically signiﬁcant association to changes in KOOS pain and function in daily living
(r  0.13; P > 0.05) or the OMERACT-OARSI Responder Criterion (OR 0.48e1.68; P-values  0.13).
Conclusions: Presence of joint damage did not preclude symptomatic relief following a clinically relevant
weight loss in older obese patients with KOA. Neither muscle strength nor knee-joint alignment was
associated with the degree of symptomatic relief.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.H. Bliddal, The Parker Insti-
ad 8, Entrance 19, DK-2000
), mikael.boesen@gmail.com
mander), robin.christensen@
h.regionh.dk (M. Henriksen),
h.regionh.dk (P. Christensen),
h.dk (J. Aaboe), bds@frh.
h.dk (B.F. Riecke), henning.
s Research Society International. PIntroduction
A treatment which efﬁciently will modify the joint destruction
of knee osteoarthritis (KOA) disease-modifying osteoarthritis drug
(DMOAD) has not yet been introduced, but recent studies have
shown a direct relationship between weight loss and the level of
symptomatic improvement in obese KOA patients1e3. These ﬁnd-
ings support earlier epidemiological ﬁndings showing that weight
loss reduces the risk of developing or experiencing progression of
KOA, and that KOA-related symptoms tend to worsen in obese
patients4e7. As a consequence, overweight KOA patients are now
recommended to lose weight as ﬁrst line therapy8. The choice ofublished by Elsevier Ltd. All rights reserved.
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particular diet composition, and the single most important factor
seems to be the establishment of a continuous energy deﬁcit9.
Conventional radiography is the simplest and least expensive
imaging method when assessing structural damage in KOA, and the
KellgreneLawrence (KL) score and minimum joint space width
(mJSW) remain the most widely applied tools when diagnosing and
following KOA in clinical trials10e12. Magnetic resonance imaging
(MRI) provides additional information to radiographs, as it has
a unique ability to image KOA-related knee-joint structures13. High-
ﬁeld MRI scans assessed by Boston-Leeds Osteoarthritis Knee Score
(BLOKS) provide additional information to radiographic scoring
methods as all relevant knee-joint structures are assessed14,15. BLOKS
provides semi-quantitative scoring of synovial thickening, osteo-
phytes, effusion, ligament damage, bone marrow lesions (BMLs),
meniscal extrusion anddamage, aswell as of cartilage abnormalities.
This structural assessment is essential since the synovium, joint
capsule and subchondral bone are highly innervated and appear to
represent some of the main origins of KOA-related pain16,17. Also,
most of these structural alterations have been shown to correlate to
clinical symptoms and/or progression of disease16,18e24.
Results from a recent study indicated that none of the assessed
structural damages on low-ﬁeld MRI (0.2 T) could rule out
a symptomatic relief obtained from weight loss25. As this obser-
vation may inﬂuence treatment strategies in terms of recom-
mending diet for the treatment of KOA symptoms, it is essential to
assess these associations using different methods for the assess-
ment of knee-joint damage. The aim of this study was to investigate
the relationship between baseline knee-joint structural damage, by
high-ﬁeld MRI, knee-joint alignment measurements and muscle
strength, and symptomatic improvement following a clinically
signiﬁcant weight loss in elderly obese patients with deﬁnite KOA.
Methods
Patient population
192 participants were recruited November 2007eAugust 2008
from the outpatient clinic at the Department of Rheumatology,
Frederiksberg Hospital, Denmark, to take part in the CAROT study
(inﬂuence of weight loss or exercise on cartilage in obese knee
osteoarthritis patients (KOA) patients: a randomized controlled trial,
CAROT ClinicalTrials.gov identiﬁer: NCT00655941)26. To be eligible
for inclusion, individuals had to be over 50 years of age, have a body
mass index (BMI) 30 kg/m2, and show primary KOA diagnosed
according to the ACR criteria27, with clinical symptoms as well as
a veriﬁed diagnosis obtained fromeither radiographs or arthroscopy.
Patients were not included if any of the following criteria were
present: lack of motivation for weight reduction; insufﬁcient verbal
or intellectual understanding; planned anti-obesity operation;
former or planned knee-joint replacement; in pharmacologic treat-
ment for obesity; medical disease that prevents physical training;
active joint disease besides KOA; signiﬁcant hip OA; toe or foot
deformity which inﬂuences gait analysis; use of morphine (nonste-
roidal anti-inﬂammatory drug (NSAID), acetyl salicylic acid (ASA)
and/or paracetamol were accepted and registered for each patient).
No patient was excluded due to their medical disease.
All patients signed and approved the informed consent. At
baseline we performed standing knee radiographs andMRI. Fasting
blood samples were taken and urine samples were collected at the
same point, and joint ﬂuid was withdrawn under ultrasound
guidance. Patient-reported outcome (PRO) questionnaires were
completed by the patients, and a clinical examination was carried
out. The study was approved by the local ethical committee of The
Capital Region of Denmark [H-B-2007-088] and was carried out inaccordance with the Helsinki Declaration II and the European
Guidelines for Good Clinical Practise.
MRI analysis
Baseline MRI was obtained of the target knee (worst symp-
tomatic) using a high-ﬁeld MRI (1.5 T) whole body scanner (Philips
Intera; software release 12.1.5.0) following normal procedure taken
one scan at each setting. Patients were positioned lying on their
back, and a send/receive ﬂex medium or large coil was ﬁxed to the
patient’s leg. The following ﬁve sequences were carried out:
Gradient echo (GRE)-scout (10 mm slices, TR 12.3 ms, TE 6.6 ms,
50 ﬂip angle, FOV 300  300, matrix 256  256). Saggital 3D Flash
GRE cartilage sequence (3 mm slices, TR 21 ms, TE 8.4 ms, 20 ﬂip
angle, FOV 160 mm  160 mm, matrix 512  512). Saggital multi-
echo T2 weighted sequence (4 mm slices, TR 2531.3 ms, TE
100 ms, FOV 170  170, matrix 256  256). Saggital multi-echo
proton density weighted (PDw) sequence (4 mm slices, TR
2531.3 ms, TE 15.4 ms, FOV 170  170, matrix 256  256). Coronal
T1 spin echo (SE) sequence (3 mm slices, TR 500 ms, TE 17 ms, FOV
150 mm  150 mm, matrix 512  512 mm). Coronal short tau
inversion recovery (STIR) sequence (3 mm slices, TR 1797.9 ms, TE
55 ms, FOV 150  150, matrix 512  512). Scheduled time for the
overall MRI examination was 37 min.
The imaging protocol used for BLOKS assessment15 in this study
was the saggital multi-echo PD and T2 weighted scans, the STIR
scan, the coronal SE T1 scan, as well as a 3D reconstruction of the
FLASH scan. Cartilage assessments were performed using the 3D
FLASH sequence28e30. BMLs appear as ill-deﬁned signal intensity
changes in the subchondral bone that are hypointense on T1w
images and hyperintense on STIR images31. Evidence support that
combining the two is highly effective for the evaluation of BML32,33,
even though some data suggests that T2w FS sequences might be
more sensitive33. The assessment of BMLs in patella was not per-
formed in this study due to inferior coverage of this part of the knee
joint. Synovitis and effusion were evaluated on PDw, T2w and STIR
sequences34 and the assessment of activity in Hoffa’s fat pad was
handled as a surrogate for whole-knee synovitis15,35. Osteophytes
were evaluated using all three planes. In the axial plane we scored
lateral and medial osteophytes on patella as well as anterior and
posterior osteophytes on femur. In the coronal plane we assessed
central weight-bearing osteophytes on tibia and femur. In the
saggital plane we examined the anterior and posterior osteophytes
on femur and tibia, as well as the superior and inferior osteophytes
on patella15. For evaluation of menisci we analysed morphology,
tears and extrusion on the coronal T1w turbo spin echo (TSE)
(body) and on the saggital T2w/PDw sequences (anterior and
posterior horns)36. Abnormalities in the anterior and posterior
cruciate ligaments were assessed using the saggital T2w and PDw
scans as recommended and previously performed34,37.
HG performed all the BLOKS assessments and measurements,
inter- and intra-reader analyses were performed by HG and MB,
yielding results equal to results from prior studies (kappa
0.51e0.90)15,38.
Radiographic measurements
Bi-plane weight-bearing semi-ﬂexed radiographs were taken of
the index knee; one in the postero-anterior and one in the lateral
view (in case of bilateral symptoms we used the most symptomatic
knee). The radiographs were obtained at inclusion/baseline by the
same radiographers, using a Philips Optimus apparatus and
a standardized protocol through all examinations.
Measurements of the mJSW in the most affected compartment
were performed by HG39. Inter- and intra-reader analyses of mJSW
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cients (ICCs) of 0.93 and 0.98, respectively, which is comparable to
the latest review on this topic40. MB analysed all radiographs using
an atlas41 and scored according to the KL grading system10.
All assessments of radiographs and MRI were performed using
the MacOS X based Osirix software (v. 3.9.1)42.
Blood sample analysis
Serum samples were produced from the collected blood
samples, frozen at 20C and stored at 80C until measurements
of all samples at the same time.
C-reactive protein (CRP) was measured in heparin plasma with
immunoturbidimetric absorption photometry (Roche/Hitachi
cobas c-systems, Roche Diagnostics GmbH, D-68298 Mannheim),
with a value 10 mg/L being considered normal concentration, to
assess possible inﬂammatory condition.
Knee-joint alignment axis
Mechanical axis alignment was measured using a 6 camera
stereophotogrammetric system (Vicon MX, Vicon, UK) with
markers placed on anatomical landmarks (second metatarsal head,
lateral malleolus, posterior aspect of calcaneus, lateral aspect of the
leg, lateral femoral epicondyle, lateral aspect of the thigh, bilaterally
on anterior and posterior superior iliac spines) according to the
Plug-in-Gait biomechanical model, and anthropometric measure-
ments (height, leg length, and knee and ankle diameters) to deter-
mine joint centres. The mechanical axis alignment was deﬁned as
the frontal plane knee-joint angle expressed in the local joint
coordinate system. This procedure yields estimates of mechanical
axis alignment similar to full-limb weight-bearing radiographs
(R2¼ 0.54) but without exposure to radiation43. A kneewas deﬁned
as a varus when alignment was >0 and valgus when <0.
Isometric maximal voluntary contraction (MVC)
Isometric MVC of hamstrings and the quadriceps muscles were
assessed by isometric dynamometry at 60 (0 is full extension)
knee-joint ﬂexion angle (Biodex System 3 PRO, Biodex Medical
System, NY, USA) as described44. After calibrating the system, the
subject was comfortably seated and fastened to the dynamometer
chair with leg- and body-straps. Prior to the measurements,
a correction for gravity was made by registering the leg’s weight at
0 knee-joint angle. After test trials, performed to familiarize the
patients to the test, the average peak value of three trials was
chosen as MVC. Vigorous verbal encouragement was given in an
attempt to achieve maximal effort level. Isometric MVC-values
were normalized to body mass (Nm/kg).
Biometric examinations
The following biometric values were measured: body weights
without large clothing and shoes to the nearest 0.1 kg on a decimal
weighing scale (TANITA BW-800, Tanita Europe BV, Hoogoorddreef
56e, 1101BE Amsterdam The Netherlands); height, using a stadi-
ometer, rounding off the values to the nearest 0.5 cm. From body
mass and height, the BMI was calculated (kg/m2).
Symptom assessment
Symptom self-assessment was done at baseline and again at
follow-up (t ¼ 16 weeks), with assessments of the Outcome
Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) -Osteoarthritis Research Society International (OARSI) Responder
Criteria and KOOS pain and function of daily living (ADL).
The OMERACT-OARSI Responder Criterion was assessed by
visual analogue scale (VAS) pain, and function and patient global
0e100 mm scales45. The Knee Injury and Osteoarthritis Outcome
Score (KOOS) assessed impairment, disability and handicap with 42
items in ﬁve domains (function of daily living, pain, knee-related
quality of life, symptoms, and function in sport/recreation). Items
are scored from 0 to 4 and then transformed into a 0e100 scale;
0 representing extreme knee-related problems and 100 repre-
senting no knee-related problems46,47.
Interventions
Thedietary intervention lasted16weeks and theﬁrst phaseof the
study consisted of an 8-week weight reduction programme where
the participants were randomized to either an all-provided very low
energy diet (VLED) with 415e554 kcal/day or an low energy diet
(LED) with 810 kcal/day in a supervised dietary programme with
weekly attendance at dieticians (products provided by The Cam-
bridge Weight Plan). The patients attended weekly sessions of
1.5e2 h and were given nutritional and dietetic instructions by an
experienced dietician. Daily intake of protein was at least 43.2 g
(1.52 oz), and the intake of essential fatty acids, linoleic acid and
linolenic acid was 3 g (0.11 oz) and 0.4 g (0.01 oz), respectively.
The second phase of the study, which was the same for all
participants, consisted of 8 weeks’ ﬁxed energy diet programme
using 1200 kcal incorporating two diet products daily. Participants
continued to attend the groups to which they were initially allo-
cated. All participants were taught to make diet plans with ﬁve to
six small meals a day. The principles of the diet were in line with
the guidelines for healthy eating issued by the Danish National
Board of Health, i.e., low-fat, low-sugar and high-ﬁbre. The focus
was on long-term lifestyle modiﬁcations; educational themes
were: energy expenditure and energy balance, macronutrients,
satiety, digestion, motivation and diet planning. The group treat-
ment provided a combination of empathy, social support and
friendly competition. Further information about the weight loss
program has been published elsewhere26,48.
Statistical methods
General notes: all results were calculated for the entire cohort
(LED and VLED), as we merely wished to assess structural damage
in relation to symptomatic response following diet intervention
and did not consider the method for obtaining this weight loss as
relevant for this study. All analyses were performed in accordance
with the principles for Intention-To-Treat (ITT) with baseline
observation carried forward for drop-outs (n ¼ 17).
Weight loss (kg)was analysed as differences frombaseline values
(x16 x0), and clinical outcomeswere analysed as a relativemeasure,
being the percentage change from baseline [(x16  x0)/x0  100%].
We performed a distribution-free Spearman’s test of rank
correlation when examining the possible relationship between
variables assessing knee structural damage and clinical outcomes
of the dietary interventions. The Spearman correlation coefﬁcient
was interpreted as follows: <0.3: none; 0.31e0.5: weak; 0.51e0.7:
strong; 0.71e0.9: very strong and >0.9: excellent. In order to
analyse the inﬂuence of measurements on the OMERACT-OARSI
Responder Criterion we applied logistic regressions.
A P-value less than 0.05 (two-tailed) or a 95% conﬁdence
interval (CI) not including the null hypothesis was regarded as
statistically signiﬁcant. All the analyses were performed on SAS
version 9.1 for Windows (Cary, NC, USA). No correction for multiple
testing was performed.
Fig. 1. Trial proﬁle.
Table I
Characteristics of all participants
Basic characteristics N ¼ 192
Female no. (%)s 155 (81%)
Age (years)s 62.5  6.4 (49.6e77.9)
Duration of KOA (years)*, s 3.0 [1.0; 4.0] (1.0e29.0)
Height (cm)s 166  10 (148e191)
Weight (kg)s 103.2  15.0 (76.0e145.3)
BMI (kg/m2)s 37.3  4.8 (30.1e54.0)
CRP (mg/L)*, d 4.4 [2.4; 7.7] (0.7e58.6)
Isometric MVC
Quadriceps muscle strength (nm/kg)*, y, # 1.1 [0.9; 1.4] (0.1e2.8)
Hamstrings muscle strength (nm/kg)*, y, # 0.5 [0.4; 0.6] (0.0e1.1)
Radiographs
KL (0e4)*, z, k 3.0 [2.0; 3.0] (1.0e4.0)
mJSW*, x, 4 2.2 [0.00; 3.8] (0.0e7.3)
MRI
Cartilage Icombo score (0e81)*, k, {, l 15.0 [6.0; 27.5] (0.0e61.0)
Cartilage IIsum of scores (0e20)*, k, l 9.0 [4.0; 11.0] (0.0e17.0)
BMLssum of size scores*, k, l 2.0 [1.0; 4.5] (0.0e9.0)
Osteophytessum of scores (0e36)*, k, l 13.0 [8.0; 18.5] (1.0e35.0)
Effusionscore (0e3)*, k, l 1.0 [0.0; 1.0] (0.0e3.0)
Synovitis(whole knee) score (0e3)*, k, l 1.0 [0.0; 1.0] (0.0e3.0)
Meniscisum of extrusion scores (0e12)*, k, l 7.0 [6.0; 9.0] (0.0e12.0)
Meniscisum of morphology scores (0e38)*, k, l 7.0 [6.0; 8.0] (0.0e11.0)
Symptomatic assessment
KOOSFunction in daily living (ADL)s 59.9  17.4 (4.7e98.5)
KOOSPains 57.3  16.1 (11.1e100)
Knee-joint alignment axis#
Varus (>0)/Valgus (<0) 5.9  4.9 (e8.6e23.7)
Pluseminus values are means  SD and (minemax) unless otherwise stated.
Number of participants included in analysis varied due to missing data for speciﬁc
variables, as follows: s 192 patients; # 177 patients; l 187 patients; k 190 patients; 4
173 patients.
* Presented as median, interquartile range [Q1; Q3] and (minemax).
y Measured isometric at 60 and normalized to body weight (nm/kg).
z Scored using the KL score.
x mJSW; minimum joint space width (mm).
k Sum of all BML size scores except those from patella.
{ For all analysed areas wemultiplied the “surface area”-score (0e3) with the “full
thickness”-score (0e3), reaching results between 0 and 9 for each area, and then
multiplied them into one “combo score” reaching a ﬁnal score between 0 and 81.
# From the static anatomical landmark calibration trials for each subject the knee-
joint mechanical axis alignment was calculated using a Plug-in-Gait model.
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During a 9-month recruitment period we performed pre-screen
interview by telephone of 388 possible subjects. Of these, 187 (48%)
patients were ineligible and nine (2%) patients declined to partic-
ipate at the screening visit, leaving 192 patients to be included at
baseline. Following the 16-week diet intervention, 175 patients still
remained in the study (Fig. 1).
The average KOA patient entering this study was a 63-year-old
womanwith a BMI of 37 having a symptomatic index of 60 on KOOS
pain and function in daily living (ADL) (Table I). This cohort dis-
played a wide variety of structural damage when assessed by MRI
and radiography. In relation to the meniscus extrusion scores most
patients had severe damage while for all other BLOKS items the
majority of patients only had mild to moderate damage. The
assessment of radiographs showed that most patients had
a diminished mJSW and that 155 patients were classiﬁed as having
mild to moderate KOA, KL 1-2.
The effect of this diet intervention was a median improvement
in symptoms from baseline to week 16 of 14.0% (KOOS pain) and
15.8% (KOOS ADL).
Measurements of structural damage at baseline were examined
as predictors of symptomatic outcome (Table II). The analysis did
not reveal any signiﬁcant correlation between symptomatic
improvement and the chosen predictors (D ADL and pain, r  0.13;
P > 0.05) except for the effusion score and D ADL (r 0.17; P ¼ 0.03).
Baseline symptoms, measured as KOOS ADL and pain, were corre-
lated to D ADL and pain.
CRP did not show a signiﬁcant correlation to symptomatic
improvement over the 16 weeks of weight loss.
Analysing the predictive effect of baseline measures of struc-
tural damage on the OMERACT-OARSI Responder Criterion, we
found that neither of our included assessment methods had any
statistically signiﬁcant impact (Table III). KOOS ADL and pain at
study start had no signiﬁcant impact on this criterion.
With respect to the effect of structural damage on biometrics,
mJSW was found to be associated to the achieved weight loss
(r ¼ 0.20, P ¼ 0.001).
Discussion
Weight loss is hard to achieve for overweight and obese elderly
individuals with limited mobility like a great part of the KOA
population. Adhering to a weight loss scheme is difﬁcult, and only
strong evidence of a positive effect will keep both the general
practitioner and patient focused on the treatment.
This study demonstrated that baseline structural damage
assessed by imaging, mechanical axis or muscle strength did not
predict the symptomatic outcome of a 16-week diet intervention in
this group of elderly female obese KOA patients. To the best of our
knowledge this is the ﬁrst study to demonstrate that the presence
of KOA-related structural joint damage, examined by a series of
different methods, did not preclude a symptomatic improvement
following a signiﬁcant weight loss. In this study the majority
of patients obtained a signiﬁcant weight reduction (>10%), and 64%
of the patients experienced a signiﬁcant symptomatic improve-
ment deﬁned by the OMERACT-OARSI Responder Criterion. The
results are consistent with prior studies investigating short-term
effects of weight loss and long-term outcome of total knee-joint
replacement1,2,49,50.
Several cross-sectional studies have investigated MRI-assessed
joint structure features in relation to e.g., clinical symptoms, and
found an association between symptoms and cartilage defects,
BMLs, osteophytes, meniscal lesions, JSW and KL51e56. A recent
meta-analysis of MRI features demonstrated that BMLs and
Table II
Correlation of baseline patient characteristics, muscle strength, imaging variables and knee-joint alignment with changes in clinical outcome following intervention
D ADL (%)* D Pain (%)y D Weight (%)
Patient characteristics
Age (years) r ¼ 0.001; (P ¼ 0.99) r ¼ 0.04; (P ¼ 0.57) r ¼ 0.06; (P ¼ 0.42)
CRP r ¼ 0.06; (P ¼ 0.44) r ¼ 0.07; (P ¼ 0.37) r ¼ 0.04; (P ¼ 0.56)
KOOS ADL r ¼ 0.34; (P < 0.0001) r ¼ 0.19; (P ¼ 0.01) r ¼ 0.05; (P ¼ 0.53)
KOOS pain r ¼ 0.22; (P < 0.0001) r ¼ 0.31; (P < 0.0001) r ¼ 0.05; (P ¼ 0.49)
Isometric MVC
Quadriceps muscle strength r ¼ 0.004; (P ¼ 0.96) r ¼ 0.02; (P ¼ 0.83) r ¼ 0.11; (P ¼ 0.16)
Hamstrings muscle strength r ¼ 0.05; (P ¼ 0.52) r ¼ 0.003; (P ¼ 0.96) r ¼ 0.10; (P ¼ 0.21)
Radiographs
mJSW r ¼ 0.01; (P ¼ 0.89) r ¼ 0.02; (P ¼ 0.81) r ¼ 0.20; (P ¼ 0.001)
KL r ¼ 0.01; (P ¼ 0.91) r ¼ 0.07; (P ¼ 0.29) r ¼ 0.04; (P ¼ 0.57)
MRI scores
Cartilage score I
Whole knee r ¼ 0.09; (P ¼ 0.24) r ¼ 0.09; (P ¼ 0.24) r ¼ 0.02; (P ¼ 0.85)
Medial tibiofemoral chamber r ¼ 0.01; (P ¼ 0.87) r ¼ 0.00; (P ¼ 0.99) r ¼ 0.03; (P ¼ 0.68)
Lateral tibiofemoral chamber r ¼ 0.10; (P ¼ 0.15) r ¼ 0.11; (P ¼ 0.13) r ¼ 0.08; (P ¼ 0.65)
Patellofemoral chamber r ¼ 0.12; (P ¼ 0.09) r ¼ 0.13; (P ¼ 0.07) r ¼ 0.07; (P ¼ 0.36)
Cartilage score II r ¼ 0.07; (P ¼ 0.33) r ¼ 0.09; (P ¼ 0.22) r ¼ 0.03; (P ¼ 0.72)
BML scores
Whole knee r ¼ 0.01; (P ¼ 0.84) r ¼ 0.04; (P ¼ 0.62) r ¼ 0.08; (P ¼ 0.26)
Medial tibiofemoral chamber r ¼ 0.05; (P ¼ 0.52) r ¼ 0.05; (P ¼ 0.48) r ¼ 0.04; (P ¼ 0.63)
Lateral tibiofemoral chamber r ¼ 0.004; (P ¼ 0.96) r ¼ 0.03; (P ¼ 0.65) r ¼ 0.08; (P ¼ 0.30)
Osteophyte scores r ¼ 0.06; (P ¼ 0.44) r ¼ 0.08; (P ¼ 0.29) r ¼ 0.02; (P ¼ 0.81)
Effusion score r ¼ 0.17; (P ¼ 0.03) r ¼ 0.02; (P ¼ 0.72) r ¼ 0.07; (P ¼ 0.37)
Synovitis score r ¼ 0.04; (P ¼ 0.60) r ¼ 0.01; (P ¼ 0.94) r ¼ 0.01; (P ¼ 0.86)
Meniscal extrusion scores
Medial tibiofemoral chamber r ¼ 0.09; (P ¼ 0.23) r ¼ 0.09; (P ¼ 0.23) r ¼ 0.02; (P ¼ 0.81)
Lateral tibiofemoral chamber r ¼ 0.04; (P ¼ 0.59) r ¼ 0.01; (P ¼ 0.87) r ¼ 0.06; (P ¼ 0.39)
Meniscal morphology scores
Medial tibiofemoral chamber r ¼ 0.07; (P ¼ 0.37) r ¼ 0.04; (P ¼ 0.60) r ¼ 0.04; (P ¼ 0.54)
Lateral tibiofemoral chamber r ¼ 0.01; (P ¼ 0.87) r ¼ 0.06; (P ¼ 0.44) r ¼ 0.03; (P ¼ 0.72)
Knee-joint alignment axis
Degree of malalignment r ¼ 0.13; (P ¼ 0.08) r ¼ 0.08; (P ¼ 0.27) r ¼ 0.01; (P ¼ 0.92)
* Analysed as a relative measure; the percentage change from baseline [(x16  x0)/x0  100%] of KOOS function in daily living.
y Analysed as a relative measure; the percentage change from baseline [(x16  x0)/x0  100%] of KOOS pain.
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observing changes in symptoms, one study investigating synovitis
at baseline and clinical symptoms after 2 months found no rela-
tionship58. This is similar to our results, while Hill et al. found
a change in synovitis to be linked to change in pain20.
We found a weak association between baseline effusion and
improvement in KOOS ADL. Further analysis showed that this
correlation was maintained only due to two outliers who experi-
enced improvements of 2e300% in KOOS function of daily living
due to a ﬂooring-phenomenon at their baseline assessments [>2
standard deviations (SDs) from themean baseline KOOS function of
daily living]. Furthermore, our evaluation of effusion was impaired
by not using contrast enhancement20,55. The observed association
between baseline mJSW and D weight was founded on a skewed
distribution due to that nearly 50 patients showed no joint space.
Baseline symptoms were associated to the level of symptomatic
improvement, but this ﬁnding may primarily be a result of the
simple fact that patients with a nearmaximal level of symptoms are
more likely to improve. Results from the analysis of baseline
symptoms in relation to the OMERACT-OARSI Responder Criterion,
did not support these ﬁndings.
This study has limitations related to the use of single MRI scans,
trial participation and population heterogeneity. First, single MRI
scans are the norm, but can result in erroneous estimations of
associations due to the natural variability of these measurements.
Using only one view for the assessment of BMLs could be limiting,
but we do not believe that this procedure is a serious limitation and
this approach is in accordance with similar research groups59,60.Second, while PROs are the preferred end points of clinical trials,
they are inﬂuenced by psychological factors, familiarity, expecta-
tions etc61,62. Participation in a trial may have a larger impact on the
result than any indicator of disease severity estimated by objective
measurements. In our study, the patient satisfaction was extremely
good, as indicated by a large degree of compliance. Third, the
heterogeneity of this cohort made it possible to explore whether or
not the degree of structural damage had any impact on the outcome
of diet intervention with regard to symptomatic improvement, but
this trait also decreased the ability to ﬁnd important associations.
Further research of symptomatic response following intervention,
in relation to changes in MRI parameters used for assessing struc-
tural damage, is the next step within this ﬁeld of research63.
Especially, it remains to be clariﬁed whether or not weight loss
and/or exercise should be the method of choice when aiming to
improve structural damage in patients with concurrent obesity
and KOA 2,26,64.
In conclusion, the present study reveals that baseline structural
joint damage assessed by MRI and radiographs, muscle strength or
knee-joint alignment did not predict the immediate improvement
in KOA symptoms following a clinically relevant weight loss over
16 weeks. These ﬁndings are valuable for future regimens of
treatment as they indicate that any obese patient, whatever the
level of knee damage, may beneﬁt from a weight-loss programme.
There is therefore strong evidence for recommending weight loss
as the ﬁrst choice of treatment for obese KOA patients whatever the
degree of structural damage in the knee may be, since it may delay
or prevent surgical interventions.
Table III
Predictors of the OMERACT-OARSI Responder Criterion
Univariate OR [CI] (P-value)
Patient characteristics
Age (years) 1.00 [0.96; 1.05] (0.88)
KOOS ADL 0.98 [0.97; 1.00] (0.07)
KOOS pain 0.99 [0.97; 1.00] (0.28)
Isometric MVC
Quadriceps muscle strength (nm/kg) 0.55 [0.26; 1.20] (0.13)
Hamstrings muscle strength (nm/kg) 0.48 [0.08; 3.08] (0.44)
Radiographs
mJSW 0.90 [0.75; 1.07] (0.22)
KL; grade 1 vs 4 1.68 [0.48; 5.85] (0.53)
KL; grade 2 vs 4 1.14 [0.50; 2.62] (0.62)
KL; grade 3 vs 4 1.46 [0.63; 3.43] (0.63)
MRI scores
Cartilage score I
Whole knee 1.01 [0.99; 1.03] (0.30)
Medial tibiofemoral chamber 0.99 [0.95; 1.04] (0.68)
Lateral tibiofemoral chamber 1.07 [0.90; 1.26] (0.46)
Patellofemoral chamber 0.98 [0.89; 1.08] (0.70)
Cartilage Score II 1.04 [0.96; 1.11] (0.32)
BML scores
Whole knee 1.02 [0.90; 1.17] (0.72)
Medial tibiofemoral chamber 1.05 [0.90; 1.22] (0.50)
Lateral tibiofemoral chamber 0.95 [0.76; 1.19] (0.66)
Osteophyte scores 0.99 [0.95; 1.03] (0.75)
Effusion score 0.83 [0.57; 1.21] (0.33)
Synovitis score 0.94 [0.60; 1.47] (0.77)
Meniscal extrusion scores
Medial tibiofemoral chamber 0.99 [0.81; 1.20] (0.91)
Lateral tibiofemoral chamber 0.94 [0.79; 1.12] (0.50)
Meniscal morphology scores
Medial tibiofemoral chamber 1.00 [0.81; 1.24] (0.99)
Lateral tibiofemoral chamber 1.06 [0.85; 1.32] (0.61)
Knee-joint alignment axis
Degree of malalignment 0.99 [0.93; 1.06] (0.78)
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